Mark Faulkner | Source | Founder and President at CON-CRĒT
Mark Faulkner
Founder and President of CON-CRĒT by Vireo Systems.
Synthesized a unique form of creatine, creatine hydrochloride (HCl), trademarked the supplement and called it CON-CRĒT. Today, CON-CRĒT is the #1 absorbed and best-selling, most widely licensed, and the first and only creatine manufactured in the USA. Scientific studies have shown it achieves at least 70% greater uptake into your bloodstream compared to creatine monohydrate, making it a more effective and potent choice for improving your body’s energy, your workouts, and your overall health. It is the only form of creatine that delivers superior performance results without adverse side effects, such as digestive distress, often associated with creatine.
-
CON-CRĒT (https://con-cret.com/)
Founder and President
-
CON-CRĒT® FOUNDER RECEIVES PATENT FOR RESEARCH SHOWING CREATINE’S ABILITY TO HELP THE BODY FIGHT CORONAVIRUSES AND INFLUENZA VIRUSES
Patent Research Notably Demonstrates the Ability of Creatine to Provide T cells (immune cells) with Added Energy to Fight Viruses and Protect Health
Article -
Antiviral therapeutic compounds and compositions for use in treatment of coronavirus and influenza virus - Patent WO-2022109465-A9 - PubChem
CON-CRĒT founder, Mark Faulkner and board member Donald Miller received a patent for research that shows supplementing with creatine enables the body to fight viral infections.
Case study
-
“Creatine is increasingly understood to be arguably the most important supplement people can take for overall health and this patent adds to the mounting research underscoring its significance,” said Faulkner. “I’m excited about the transformative potential this research has on the ability to strengthen the immune system and fight viruses, as well as on other fields of health.” - In reference to receiving a patent for research that shows creatine's ability to help the body fight against coronaviruses and influenza viruses.